Skip to main content
Livermore
Livermore
ZHEN

Lipe & Dalton

SEC CIK
0001570396
Latest filing
Jul 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q2 2021
Holdings of REGN by Lipe & Dalton, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−289−100.0%Sold outHolders
Q1 2026289$223.0K0.1%−20−6.5%ReducedHolders
Q4 2025309$239.0K0.1%+309NewHolders
Q1 20250$00.0%−269−100.0%Sold outHolders
Q4 2024269$192.0K0.1%00.0%UnchangedHolders
Q3 2024269$283.0K0.1%00.0%UnchangedHolders
Q2 2024269$283.0K0.2%00.0%UnchangedHolders
Q1 2024269$259.0K0.1%00.0%UnchangedHolders
Q4 2023269$236.0K0.1%00.0%UnchangedHolders
Q3 2023269$221.0K0.1%00.0%UnchangedHolders
Q2 2023269$193.0K0.1%−20−6.9%ReducedHolders
Q1 2023289$237.0K0.1%00.0%UnchangedHolders
Q4 2022289$209.0K0.1%−20−6.5%ReducedHolders
Q3 2022309$213.0K0.1%00.0%UnchangedHolders
Q2 2022309$183.0K0.1%00.0%UnchangedHolders
Q1 2022309$216.0K0.1%00.0%UnchangedHolders
Q4 2021309$195.0K0.1%+100+47.8%AddedHolders
Q3 2021209$126.0K0.1%00.0%UnchangedHolders
Q2 2021209$117.0K0.1%+209NewHolders